GPT-5 lowers the cost of cell-free protein synthesis

OpenAI's GPT-5 has been integrated into an autonomous laboratory system with Ginkgo Bioworks' cloud automation platform to perform cell-free protein synthesis. In a closed-loop experimental process, GPT-5 analyzed results and designed subsequent experiments, reducing synthesis costs by 40% compared to traditional methods, according to the OpenAI Blog. Cell-free protein synthesis is a biotechnology technique that produces proteins without living cells, but it is often costly. By automating the design-build-test-learn cycle with a large language model, the system optimized protocols and minimized waste. For developers building AI workflows, this demonstrates how AI can drive scientific experimentation when paired with robotic automation and data analysis, providing a template for integrating AI into R&D pipelines beyond software into wet-lab processes. While the direct application to typical software workflows may be limited, the concept of closed-loop optimization using AI is broadly transferable.